Becton, Dickinson slips 9% on guidance cut

Becton, Dickinson (BDX) FQ1 results: Revenues: $4,225M (+1.6%); BD Medical: $1,204M (-2.8%); BD Life Sciences: $538M (+11.2%); BD Interventional: $688M (+3.6%).

Net Income: $240M (-57.3%); EPS: $0.87 (-57.6%); non-GAAP EPS: $2.65 (-1.9%); CF Ops: $713M.

Fiscal 2020 guidance: Revenue growth: 1.5% – 2.5% from 4.0 – 4.5%; non-GAAP EPS: $11.90 – 12.10 from $12.50 – 12.65.

Shares are down 9% premarket.

Previously: Becton, Dickinson EPS beats by $0.01, beats on revenue (Feb. 6)

https://seekingalpha.com/news/3539153-becton-dickinson-slips-9-on-guidance-cut